The MHRA ( Medicines and Healthcare products Regulatory Agency ) has two main application procedures: Simple Reclassification : This is a straightforward and quick procedure based on an analogous product (a medicinal product already on the UK market with the same active ingredient, route of administration, use, and a similar or higher strength/dosage)
High-Potency B6, B1, B2, B7, B9 Tablets: Targeted formulas for specific health needs (e.g., pregnancy, hair growth)
Its nothing short of a scandal how so many patients with severe B12 deficiency are being refused repeat prescriptions for B12 shots
8-12 hours IM) Preferred by 64% of patients who've tried both Intramuscular (into deltoid or vastus lateralis, using a 22-25 gauge, 1-inch needle): 41% report injection-site soreness Faster absorption More difficult self-administration for some sites (deltoid requires non-dominant arm injection) Preferred by 36% of patients who've tried both The efficacy difference is minimal
This way your medical needs stay as private as possible
B12 plays a key role in making red blood cells, which carry oxygen throughout your body
